StonvexLoading…
StonvexStonvexStonvexCore line items from NUTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $2.04M | $1.28M | $887.71K | $714.26K |
Operating Income | $-1.39M | $-147.56K | $-519.58K | $-446.49K |
Net Income | $-579.58K | $384.11K | $-483.08K | $-440.04K |
EPS (Diluted) | $-0.06 | $0.05 | $-0.12 | $-0.36 |
Total Assets | $27.01M | $19.26M | Not available | Not available |
Total Liabilities | $16.39M | $22.96M | Not available | Not available |
Cash & Equivalents | $5.10M | $6.92M | $3.37M | $286.64K |
Free Cash Flow OCF − CapEx | $-18.47M | $-1.51M | $2.74M | Not available |
Shares Outstanding | 19.38M | 15.07M | 4.12M | 1.23M |